Search
for
Sort by
Research 15
- Aldesleukin
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Index
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Cutaneous drug reactions
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- NEFAZODONE
- ESCITALOPRAM
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- New Modalities in the Treatment of Refractory Alopecia Areata
- ZALCITABINE
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años